顎関節症に対するＡｍｆｅｎａｃ　ｓｏｄｉｕｍ（フェナゾックス）の臨床評価

DOI 被引用文献5件

書誌事項

タイトル別名
  • Clinical evaluation of amfenac sodium(Fenazox) for temporomandibular arthrosis.

この論文をさがす

抄録

The efficacy of Amfenac Sodium (Fenazox®), nonsteroid anti-inflammatory agent on temporomandibular joint pain was clinically evaluated in 28 temporomandibular arthrosis patients. Amfenac Sodium dosage of 200 mg was given orally in 4 times daily for two weeks.<BR>The results were as follows:<BR>1) Temporomandibular joint pain and limitation of mouth opening because of pain improved remarkedly.<BR>2) Effectiveness of Amfenac Sodium was “Excellent” in 5 cases (17.9%), “Good” in 12 cases (42.9%) and “Fair” in 10 cases (35.7%).<BR>3) Side effects were observed in 8 of the 28 cases. Most of those 3 cases had slight gastrointestinal disorders and only two cases were dropped.<BR>4) The usefulness of Amfenac Sodium was in 3 cases (10.7%) “Excellent”, 13 cases (46.4%) “Good” and 10 cases (35.7%) “Fair”.<BR>It is suggested that Amfenac Sodium is useful for relief from temporomandibular joint pain in temporomandibular arthrosis patients.

収録刊行物

被引用文献 (5)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ